Tissue Scaffold With Microbubble-Induced Fluid Flow
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current scaffolds for tissue engineering face challenges in directing the timing and coordination of cytokine and growth factor influence during wound healing, limited by passive diffusion and potential immunogenic responses, leading to suboptimal tissue regeneration.
Innovation Solution
The use of scaffolds with a luminal surface coated with a gel or liquid composition containing microbubbles, which are disrupted to induce active fluid flow, combined with a source of reduced pressure and a manifold for distributing pressure, facilitating controlled tissue growth and regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If traditional passive diffusion is used for cytokine and growth factor delivery in scaffolds, then the system is simple to implement, but the timing and coordination of factor delivery cannot be controlled, leading to suboptimal tissue regeneration
Solution Approach 1:
The scaffold system transitions from a static passive diffusion approach to a dynamic active flow system. Fluid flow through the scaffold is controlled by adjusting pressure differentials, allowing the system to adapt delivery rates and timing to match the sequential requirements of different wound healing stages (hemostasis, inflammation, repair, remodeling).
Solution Approach 2:
The system changes the physical state and delivery parameters of bioactive factors by transitioning from diffusion-based transport to convection-driven flow. By controlling flow rate, pressure, and timing, the system can deliver cytokines and growth factors in coordinated sequences that match biological healing requirements, significantly improving tissue regeneration outcomes.
2Productivity
If exogenous cells are introduced to accelerate tissue repair, then the speed of healing is improved, but immunogenicity and cell viability maintenance become problematic
Solution Approach 1:
The scaffold acts as an intermediary system that delivers endogenous cytokines and growth factors in controlled sequences, eliminating the need for exogenous cell introduction. The fluid flow system transports bioactive molecules from reservoirs within the scaffold to the wound site, achieving accelerated healing without the immunogenicity and viability challenges of transplanted cells.
3Stability of the object's composition
If synthetic scaffolds are used to provide structural framework, then the scaffold structure is stable and controllable, but the scaffolds elicit immunogenic or foreign body responses that elongate repair time
Solution Approach 1:
The scaffold employs composite material construction combining biocompatible structural components with integrated fluid delivery channels and bioactive factor reservoirs. This composite design maintains structural stability while the controlled delivery of anti-inflammatory and pro-healing cytokines actively suppresses foreign body responses, thereby reducing repair time despite the presence of synthetic materials.
4Ease of operation
If reduced pressure is applied through a porous pad, then fluid distribution is achieved, but the pad cannot actively guide the timing and coordination of bioactive agent delivery
Solution Approach 1:
The scaffold system performs preliminary action by pre-loading cytokines and growth factors into reservoirs within the scaffold structure before implantation. The integrated fluid flow system then activates sequential delivery according to the wound healing timeline, with different factors released at predetermined times to match the requirements of each healing stage (hemostasis, inflammation, repair, remodeling).
Solution Approach 2:
The system employs pneumatic principles using reduced pressure applied through a manifold to drive fluid flow through the scaffold. This hydraulic flow mechanism actively transports bioactive agents from reservoirs through channels to the wound site, providing controlled and coordinated delivery that surpasses the passive distribution capability of traditional porous pads.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances tissue regeneration by actively guiding fluid flow and bioactive agent delivery, overcoming limitations of passive diffusion and immunogenic responses, leading to more effective tissue repair and growth.
Implementation Method 1
a gel or liquid composition disposed on at least a portion of the luminal surface, the gel or liquid composition adapted to include microbubbles
Implementation Method 2
a source of reduced pressure and a manifold for distributing pressure
Data Source
AI summary
Provided is an apparatus that includes a scaffold with a gel or liquid composition deposed on at least a portion of a luminal surface, the gel or liquid composition adapted to include microbubbles. Also provided is a system that includes a source of reduced pressure, the above scaffold, a manifold adjacent the scaffold, and a conduit for providing fluid communication between the manifold and the source of reduced pressure. Additionally provided is a method that includes implanting the above scaffold at the tissue site and disrupting a substantial portion of the microbubbles to induce fluid flow to the scaffold. Further provided is an apparatus that includes a scaffold that comprises a slowly degradable material and a quickly degradable material. Additionally provided is a system for coupling nerve tissue and a microchip assembly.